Undersøgelse for at vurdere effektiviteten og sikkerheden af Ublituximab + Umbralisib med eller uden Bendamustine og Umbralisib alene hos patienter med tidligere behandlet non-Hodgkins lymfom (UNITY-NHL)
En fase 2b randomiseret undersøgelse for at vurdere effektiviteten og sikkerheden af kombinationen af Ublituximab + Umbralisib med eller uden Bendamustine og Umbralisib alene hos patienter med tidligere behandlet non-Hodgkins lymfom
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Fase 2
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
-
Gosford, Australien, 2076
- TG Therapeutics Investigational Trial Site
-
-
New South Wales
-
Gosford, New South Wales, Australien, 02250
- TG Therapeutics Investigational Trial Site
-
Wahroonga, New South Wales, Australien, 02076
- TG Therapeutics Investigational Trial Site
-
-
Queensland
-
Benowa, Queensland, Australien, 04217
- TG Therapeutics Investigational Trial Site
-
South Brisbane, Queensland, Australien, 04101
- TG Therapeutics Investigational Trial Site
-
-
South Australia
-
Adelaide, South Australia, Australien, 05000
- TG Therapeutics Investigational Trial Site
-
-
Victoria
-
Heidelberg, Victoria, Australien, 03084
- TG Therapeutics Investigational Trial Site
-
-
Western Australia
-
Nedlands, Western Australia, Australien, 06009
- TG Therapeutics Investigational Trial Site
-
Netherlands, Western Australia, Australien, 06009
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Cambridge, Det Forenede Kongerige, CB2-0QQ
- TG Therapeutics Investigational Trial Site
-
Denmark Hill, Det Forenede Kongerige, SE5-9RS
- TG Therapeutics Investigational Trial Site
-
Leeds, Det Forenede Kongerige, LS97TF
- TG Therapeutics Investigational Trial Site
-
Liverpool, Det Forenede Kongerige, L7-8XP
- TG Therapeutics Investigational Trial Site
-
London, Det Forenede Kongerige, SW170QT
- TG Therapeutics Investigational Trial Site
-
London, Det Forenede Kongerige, EC1A-7BE
- TG Therapeutics Investigational Trial Site
-
Oxford, Det Forenede Kongerige, OX37LE
- TG Therapeutics Investigational Trial Site
-
Plymouth, Det Forenede Kongerige, PL68DH
- TG Therapeutics Investigational Trial Site
-
-
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35243
- TG Therapeutics Investigational Trial Site
-
Huntsville, Alabama, Forenede Stater, 35805
- TG Therapeutics Investigational Trial Site
-
-
Arizona
-
Chandler, Arizona, Forenede Stater, 85224
- TG Therapeutics Investigational Trial Site
-
Tucson, Arizona, Forenede Stater, 85711
- TG Therapeutics Investigational Trial Site
-
Tucson, Arizona, Forenede Stater, 85724
- TG Therapeutics Investigational Trial Site
-
-
California
-
Los Angeles, California, Forenede Stater, 90095
- TG Therapeutics Investigational Trial Site
-
Orange, California, Forenede Stater, 92868
- TG Therapeutics Investigational Trial Site
-
San Diego, California, Forenede Stater, 92108
- TG Therapeutics Investigational Trial Site
-
San Diego, California, Forenede Stater, 90710
- TG Therapeutics Investigational Trial Site
-
Whittier, California, Forenede Stater, 90603
- TG Therapeutics Investigational Trial Site
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80012
- TG Therapeutics Investigational Trial Site
-
Denver, Colorado, Forenede Stater, 80218
- TG Therapeutics Investigational Trial Site
-
Fort Collins, Colorado, Forenede Stater, 80528
- TG Therapeutics Investigational Trial Site
-
-
Connecticut
-
Bridgeport, Connecticut, Forenede Stater, 06606
- TG Therapeutics Investigational Trial Site
-
-
Delaware
-
Newark, Delaware, Forenede Stater, 19713
- TG Therapeutics Investigational Trial Site
-
-
District of Columbia
-
Washington, District of Columbia, Forenede Stater, 20007
- TG Therapeutics Investigational Trial Site
-
-
Florida
-
Boca Raton, Florida, Forenede Stater, 33486
- TG Therapeutics Investigational Trial Site
-
Fort Myers, Florida, Forenede Stater, 33916
- TG Therapeutics Investigational Trial Site
-
Gainesville, Florida, Forenede Stater, 32608
- TG Therapeutics Investigational Trial Site
-
Jacksonville, Florida, Forenede Stater, 32224
- TG Therapeutics Investigational Trial Site
-
Jacksonville, Florida, Forenede Stater, 32204
- TG Therapeutics Investigational Trial Site
-
Jacksonville, Florida, Forenede Stater, 32256
- TG Therapeutics Investigational Trial Site
-
Miami, Florida, Forenede Stater, 33176
- TG Therapeutics Investigational Trial Site
-
Saint Petersburg, Florida, Forenede Stater, 33705
- TG Therapeutics Investigational Trial Site
-
Tallahassee, Florida, Forenede Stater, 32308
- TG Therapeutics Investigational Trial Site
-
Tampa, Florida, Forenede Stater, 33612
- TG Therapeutics Investigational Trial Site
-
West Palm Beach, Florida, Forenede Stater, 33407
- TG Therapeutics Investigational Trial Site
-
-
Georgia
-
Albany, Georgia, Forenede Stater, 31701
- TG Therapeutics Investigational Trial Site
-
Macon, Georgia, Forenede Stater, 31201
- TG Therapeutics Investigational Trial Site
-
Marietta, Georgia, Forenede Stater, 30060
- TG Therapeutics Investigational Trial Site
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60612
- TG Therapeutics Investigational Trial Site
-
Chicago, Illinois, Forenede Stater, 60637
- TG Therapeutics Investigational Trial Site
-
Decatur, Illinois, Forenede Stater, 62526
- TG Therapeutics Investigational Trial Site
-
Evanston, Illinois, Forenede Stater, 60201
- TG Therapeutics Investigational Trial Site
-
Harvey, Illinois, Forenede Stater, 60426
- TG Therapeutics Investigational Trial Site
-
Maywood, Illinois, Forenede Stater, 60153
- TG Therapeutics Investigational Trial Site
-
Niles, Illinois, Forenede Stater, 60714
- TG Therapeutics Investigational Trial Site
-
Peoria, Illinois, Forenede Stater, 61615
- TG Therapeutics Investigational Trial Site
-
Swansea, Illinois, Forenede Stater, 62226
- TG Therapeutics Investigational Trial Site
-
-
Indiana
-
Fort Wayne, Indiana, Forenede Stater, 46845
- TG Therapeutics Investigational Trial Site
-
Indianapolis, Indiana, Forenede Stater, 46237
- TG Therapeutics Investigational Trial Site
-
-
Kansas
-
Westwood, Kansas, Forenede Stater, 66210
- TG Therapeutics Investigational Trial Site
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40207
- TG Therapeutics Investigational Trial Site
-
-
Louisiana
-
Covington, Louisiana, Forenede Stater, 70433
- TG Therapeutics Investigational Trial Site
-
-
Maine
-
Brewer, Maine, Forenede Stater, 04412
- TG Therapeutics Investigational Trial Site
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21201
- TG Therapeutics Investigational Trial Site
-
Bethesda, Maryland, Forenede Stater, 20817
- TG Therapeutics Investigational Trial Site
-
Columbia, Maryland, Forenede Stater, 21044
- TG Therapeutics Investigational Trial Site
-
Towson, Maryland, Forenede Stater, 21204
- TG Therapeutics Investigational Trial Site
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48109
- TG Therapeutics Investigational Trial Site
-
-
Minnesota
-
Duluth, Minnesota, Forenede Stater, 55805
- TG Therapeutics Investigational Trial Site
-
Saint Louis Park, Minnesota, Forenede Stater, 55416
- TG Therapeutics Investigational Trial Site
-
-
Missouri
-
Columbia, Missouri, Forenede Stater, 65212
- TG Therapeutics Investigational Trial Site
-
Kansas City, Missouri, Forenede Stater, 64132
- TG Therapeutics Investigational Trial Site
-
Saint Louis, Missouri, Forenede Stater, 63110
- TG Therapeutics Investigational Trial Site
-
-
Montana
-
Billings, Montana, Forenede Stater, 59102
- TG Therapeutics Investigational Trial Site
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater, 68510
- TG Therapeutics Investigational Trial Site
-
Omaha, Nebraska, Forenede Stater, 68130
- TG Therapeutics Investigational Trial Site
-
-
New Hampshire
-
Lebanon, New Hampshire, Forenede Stater, 03756
- TG Therapeutics Investigational Trial Site
-
-
New Jersey
-
Hackensack, New Jersey, Forenede Stater, 07601
- TG Therapeutics Investigational Trial Site
-
Morristown, New Jersey, Forenede Stater, 07962
- TG Therapeutics Investigational Trial Site
-
Mount Holly, New Jersey, Forenede Stater, 08060
- TG Therapeutics Investigational Trial Site
-
-
New Mexico
-
Farmington, New Mexico, Forenede Stater, 87401
- TG Therapeutics Investigational Trial Site
-
-
New York
-
Bronx, New York, Forenede Stater, 10467
- TG Therapeutics Investigational Trial Site
-
Buffalo, New York, Forenede Stater, 14263
- TG Therapeutics Investigational Trial Site
-
New York, New York, Forenede Stater, 10019
- TG Therapeutics Investigational Trial Site
-
Syracuse, New York, Forenede Stater, 13210
- TG Therapeutics Investigational Trial Site
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28201
- TG Therapeutics Investigational Trial Site
-
Durham, North Carolina, Forenede Stater, 27705
- TG Therapeutics Investigational Trial Site
-
Hickory, North Carolina, Forenede Stater, 28602
- TG Therapeutics Investigational Trial Site
-
Kinston, North Carolina, Forenede Stater, 28501
- TG Therapeutics Investigational Trial Site
-
Raleigh, North Carolina, Forenede Stater, 27607
- TG Therapeutics Investigational Trial Site
-
Washington, North Carolina, Forenede Stater, 27889
- TG Therapeutics Investigational Trial Site
-
-
Ohio
-
Canton, Ohio, Forenede Stater, 44718
- TG Therapeutics Investigational Trial Site
-
Cincinnati, Ohio, Forenede Stater, 45220
- TG Therapeutics Investigational Trial Site
-
Cincinnati, Ohio, Forenede Stater, 45242
- TG Therapeutics Investigational Trial Site
-
Cleveland, Ohio, Forenede Stater, 44106
- TG Therapeutics Investigational Trial Site
-
Columbus, Ohio, Forenede Stater, 43219
- TG Therapeutics Investigational Trial Site
-
Toledo, Ohio, Forenede Stater, 43623
- TG Therapeutics Investigational Trial Site
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97227
- TG Therapeutics Investigational Trial Site
-
Portland, Oregon, Forenede Stater, 97213
- TG Therapeutics Investigational Trial Site
-
Springfield, Oregon, Forenede Stater, 97477
- TG Therapeutics Investigational Trial Site
-
-
Pennsylvania
-
Camp Hill, Pennsylvania, Forenede Stater, 17011
- TG Therapeutics Investigational Trial Site
-
Philadelphia, Pennsylvania, Forenede Stater, 19106
- TG Therapeutics Investigational Trial Site
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02906
- TG Therapeutics Investigational Trial Site
-
-
South Carolina
-
Greenville, South Carolina, Forenede Stater, 29615
- TG Therapeutics Investigational Trial Site
-
-
South Dakota
-
Sioux Falls, South Dakota, Forenede Stater, 57105
- TG Therapeutics Investigational Trial Site
-
Watertown, South Dakota, Forenede Stater, 57201
- TG Therapeutics Investigational Trial Site
-
-
Tennessee
-
Chattanooga, Tennessee, Forenede Stater, 37404
- TG Therapeutics Investigational Trial Site
-
Kingsport, Tennessee, Forenede Stater, 37660
- TG Therapeutics Investigational Trial Site
-
Knoxville, Tennessee, Forenede Stater, 37916
- TG Therapeutics Investigational Trial Site
-
Memphis, Tennessee, Forenede Stater, 38120
- TG Therapeutics Investigational Trial Site
-
-
Texas
-
Austin, Texas, Forenede Stater, 78705
- TG Therapeutics Investigational Trial Site
-
Dallas, Texas, Forenede Stater, 75390
- TG Therapeutics Investigational Trial Site
-
Fort Sam Houston, Texas, Forenede Stater, 78234
- TG Therapeutics Investigational Trial Site
-
Houston, Texas, Forenede Stater, 77030
- TG Therapeutics Investigational Trial Site
-
San Antonio, Texas, Forenede Stater, 78229
- TG Therapeutics Investigational Trial Site
-
San Antonio, Texas, Forenede Stater, 78217
- TG Therapeutics Investigational Trial Site
-
San Antonio, Texas, Forenede Stater, 78130
- TG Therapeutics Investigational Trial Site
-
Tyler, Texas, Forenede Stater, 75702
- TG Therapeutics Investigational Trial Site
-
-
Utah
-
Ogden, Utah, Forenede Stater, 84403
- TG Therapeutics Investigational Trial Site
-
-
Virginia
-
Blacksburg, Virginia, Forenede Stater, 24060
- TG Therapeutics Investigational Trial Site
-
Newport News, Virginia, Forenede Stater, 23601
- TG Therapeutics Investigational Trial Site
-
-
Washington
-
Olympia, Washington, Forenede Stater, 98502
- TG Therapeutics Investigational Trial Site
-
Seattle, Washington, Forenede Stater, 98109
- TG Therapeutics Investigational Trial Site
-
Seattle, Washington, Forenede Stater, 98104
- TG Therapeutics Investigational Trial Site
-
Seattle, Washington, Forenede Stater, 98108
- TG Therapeutics Investigational Trial Site
-
Spokane, Washington, Forenede Stater, 99216
- TG Therapeutics Investigational Trial Site
-
Vancouver, Washington, Forenede Stater, 97277
- TG Therapeutics Investigational Trial Site
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53792
- TG Therapeutics Investigational Trial Site
-
Wauwatosa, Wisconsin, Forenede Stater, 53226
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Ashkelon, Israel, 7830604
- TG Therapeutics Investigational Trial Site
-
Be'er Sheva, Israel, 8410101
- TG Therapeutics Investigational Trial Site
-
Haifa, Israel, 91031
- TG Therapeutics Investigational Trial Site
-
Jerusalem, Israel, 9112001
- TG Therapeutics Investigational Trial Site
-
Nahariya, Israel, 2210001
- TG Therapeutics Investigational Trial Site
-
Petah Tikva, Israel, 49100
- TG Therapeutics Investigational Trial Site
-
Tel Aviv, Israel, 64239
- TG Therapeutics Investigational Trial Site
-
Tel Aviv, Israel, 6971028
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Bologna, Italien, 40138
- TG Therapeutics Investigational Trial Site
-
Ferrara, Italien, 44020
- TG Therapeutics Investigational Trial Site
-
Milan, Italien, 20132
- TG Therapeutics Investigational Trial Site
-
Milan, Italien, 20141
- TG Therapeutics Investigational Trial Site
-
Rome, Italien, 00161
- TG Therapeutics Investigational Trial Site
-
Torino, Italien, 10126
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Busan, Korea, Republikken, 47392
- TG Therapeutics Investigational Trial Site
-
Busan, Korea, Republikken, 49241
- TG Therapeutics Investigational Trial Site
-
Gyeonggi-do, Korea, Republikken, 13620
- TG Therapeutics Investigational Trial Site
-
Incheon, Korea, Republikken, 21565
- TG Therapeutics Investigational Trial Site
-
Seoul, Korea, Republikken, 03080
- TG Therapeutics Investigational Trial Site
-
Seoul, Korea, Republikken, 06351
- TG Therapeutics Investigational Trial Site
-
Seoul, Korea, Republikken, 06591
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Chorzów, Polen, 41-500
- TG Therapeutics Investigational Trial Site
-
Gdynia, Polen, 81-519
- TG Therapeutics Investigational Trial Site
-
Kraków, Polen, 30-510
- TG Therapeutics Investigational Trial Site
-
Lublin, Polen, 20-090
- TG Therapeutics Investigational Trial Site
-
Słupsk, Polen, 76-200
- TG Therapeutics Investigational Trial Site
-
Warszawa, Polen, 02-781
- TG Therapeutics Investigational Trial Site
-
Warszawa, Polen, 02-106
- TG Therapeutics Investigational Trial Site
-
Wrocław, Polen, 50-367
- TG Therapeutics Investigational Trial Site
-
Łódź, Polen, 93-513
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Bratislava, Slovakiet, 81250
- TG Therapeutics Investigational Trial Site
-
Bratislava, Slovakiet, 83310
- TG Therapeutics Investigational Trial Site
-
Košice, Slovakiet, 04191
- TG Therapeutics Investigational Trial Site
-
Poprad, Slovakiet, 05801
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Barcelona, Spanien, 08035
- TG Therapeutics Investigational Trial Site
-
Barcelona, Spanien, 08041
- TG Therapeutics Investigational Trial Site
-
Madrid, Spanien, 28041
- TG Therapeutics Investigational Trial Site
-
Madrid, Spanien, 28222
- TG Therapeutics Investigational Trial Site
-
Salisbury, Spanien, 37007
- TG Therapeutics Investigational Trial Site
-
Valencia, Spanien, 46010
- TG Therapeutics Investigational Trial Site
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inklusionskriterier:
- Diagnose af non-Hodgkins lymfom inklusive follikulært, mantelcellelymfom og marginal zone lymfom
- Tilbagefald eller refraktær over for tidligere standardbehandling og forsøgspersoner, der ikke er kandidater til højdosisbehandling eller autolog stamcelletransplantation
- MCL-personer med en eller flere behandlingslinjer inklusive mindst én BTK-hæmmer (kun ibrutinib, acalabrutinib eller zanibrutinib)
Ekskluderingskriterier:
- Enhver større operation, kemoterapi eller immunterapi inden for de sidste 21 dage
- Tegn på hepatitis B-virus, hepatitis C-virus eller kendt HIV-infektion
- Autolog hæmatologisk stamcelletransplantation inden for 6 måneder efter studiestart. Tidligere allogen hæmatologisk stamcelletransplantation er udelukket
- Forudgående behandling med en PI3K delta-hæmmer
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: BEHANDLING
- Tildeling: TILFÆLDIGT
- Interventionel model: PARALLEL
- Maskning: INGEN
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
EKSPERIMENTEL: Umbralisib + Ublituximab
Umbralisib oral daglig dosis i kombination med Ublituximab intravenøs administration
|
Andre navne:
Andre navne:
|
|
EKSPERIMENTEL: Umbralisib
Umbralisib oral daglig dosis
|
Andre navne:
|
|
EKSPERIMENTEL: Umbralisib + Ublituximab + Bendamustine
Umbralisib oral daglig dosis i kombination med Ublituximab intravenøs administration og Bendamustine intravenøs administration
|
Andre navne:
Andre navne:
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Samlet svarprocent
Tidsramme: Hver 8.-12. uge, op til 2 år
|
Hver 8.-12. uge, op til 2 år
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Progressionsfri overlevelse
Tidsramme: Fra dato for randomisering til dato for første dokumenterede progression, vurderet op til 2 år
|
Fra dato for randomisering til dato for første dokumenterede progression, vurderet op til 2 år
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studiestol: Owen A O'Connor, MD, PhD, Columbia University
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (FAKTISKE)
Studiestart
Primær færdiggørelse (FAKTISKE)
Primær færdiggørelse
Studieafslutning (FAKTISKE)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (SKØN)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (FAKTISKE)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Sygdomme i immunsystemet
- Neoplasmer efter histologisk type
- Neoplasmer
- Lymfoproliferative lidelser
- Lymfesygdomme
- Immunproliferative lidelser
- Leukæmi, lymfoid
- Leukæmi
- Leukæmi, B-celle
- Lymfom, B-celle
- Lymfom
- Lymfom, stor B-celle, diffus
- Lymfom, Non-Hodgkin
- Lymfom, kappecelle
- Leukæmi, lymfatisk, kronisk, B-celle
- Molekylære mekanismer for farmakologisk virkning
- Antineoplastiske midler
- Antineoplastiske midler, Alkylering
- Alkyleringsmidler
- Bendamustine hydrochlorid
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- UTX-TGR-205
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .